Screener
Crinetics Pharmaceuticals CRNX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.8B.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's market capitalization?
- Crinetics Pharmaceuticals (CRNX) reported market capitalization of $3.8B in Q1 2026.
- How has Crinetics Pharmaceuticals's market capitalization changed year-over-year?
- Crinetics Pharmaceuticals's market capitalization increased by 21.9% year-over-year, from $3.12B to $3.8B.
- What is the long-term trend for Crinetics Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's market capitalization has grown at a 45.8% compound annual growth rate (CAGR), from $670.22M to $4.42B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Crinetics Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude